nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Carnitine—XDH—Azathioprine—systemic scleroderma	0.265	0.397	CbGbCtD
L-Carnitine—CES1—Mycophenolate mofetil—systemic scleroderma	0.25	0.375	CbGbCtD
L-Carnitine—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0859	0.129	CbGbCtD
L-Carnitine—SLCO1B1—Methotrexate—systemic scleroderma	0.0345	0.0516	CbGbCtD
L-Carnitine—SLC22A8—Methotrexate—systemic scleroderma	0.0318	0.0477	CbGbCtD
L-Carnitine—CROT—smooth muscle tissue—systemic scleroderma	0.00468	0.0479	CbGeAlD
L-Carnitine—CROT—skin of body—systemic scleroderma	0.00462	0.0472	CbGeAlD
L-Carnitine—SLC25A20—connective tissue—systemic scleroderma	0.00445	0.0455	CbGeAlD
L-Carnitine—MPO—artery—systemic scleroderma	0.00413	0.0422	CbGeAlD
L-Carnitine—SLC25A20—skin of body—systemic scleroderma	0.00402	0.0411	CbGeAlD
L-Carnitine—CRAT—smooth muscle tissue—systemic scleroderma	0.00395	0.0404	CbGeAlD
L-Carnitine—CRAT—skin of body—systemic scleroderma	0.0039	0.0399	CbGeAlD
L-Carnitine—CROT—tendon—systemic scleroderma	0.00352	0.036	CbGeAlD
L-Carnitine—CPT1A—connective tissue—systemic scleroderma	0.0035	0.0358	CbGeAlD
L-Carnitine—MPO—endothelium—systemic scleroderma	0.00349	0.0356	CbGeAlD
L-Carnitine—SLC25A29—lung—systemic scleroderma	0.00337	0.0344	CbGeAlD
L-Carnitine—CPT2—connective tissue—systemic scleroderma	0.00332	0.034	CbGeAlD
L-Carnitine—MPO—blood vessel—systemic scleroderma	0.00322	0.0328	CbGeAlD
L-Carnitine—CROT—lung—systemic scleroderma	0.00309	0.0316	CbGeAlD
L-Carnitine—SLC25A20—tendon—systemic scleroderma	0.00306	0.0313	CbGeAlD
L-Carnitine—CPT2—skin of body—systemic scleroderma	0.003	0.0307	CbGeAlD
L-Carnitine—CRAT—tendon—systemic scleroderma	0.00297	0.0303	CbGeAlD
L-Carnitine—SLC25A20—lung—systemic scleroderma	0.00269	0.0275	CbGeAlD
L-Carnitine—CRAT—lung—systemic scleroderma	0.00261	0.0266	CbGeAlD
L-Carnitine—CPT1A—digestive system—systemic scleroderma	0.00253	0.0258	CbGeAlD
L-Carnitine—CPT1A—tendon—systemic scleroderma	0.00241	0.0246	CbGeAlD
L-Carnitine—CPT2—tendon—systemic scleroderma	0.00229	0.0233	CbGeAlD
L-Carnitine—CPT1A—lung—systemic scleroderma	0.00211	0.0216	CbGeAlD
L-Carnitine—CPT2—lung—systemic scleroderma	0.00201	0.0205	CbGeAlD
L-Carnitine—CES1—connective tissue—systemic scleroderma	0.00197	0.0202	CbGeAlD
L-Carnitine—XDH—digestive system—systemic scleroderma	0.00187	0.0191	CbGeAlD
L-Carnitine—MPO—connective tissue—systemic scleroderma	0.00165	0.0168	CbGeAlD
L-Carnitine—MPO—skin of body—systemic scleroderma	0.00149	0.0152	CbGeAlD
L-Carnitine—CES1—digestive system—systemic scleroderma	0.00143	0.0146	CbGeAlD
L-Carnitine—SLCO1B1—digestive system—systemic scleroderma	0.00123	0.0125	CbGeAlD
L-Carnitine—CES1—lung—systemic scleroderma	0.00119	0.0122	CbGeAlD
L-Carnitine—MPO—digestive system—systemic scleroderma	0.00119	0.0122	CbGeAlD
L-Carnitine—SLC22A4—digestive system—systemic scleroderma	0.00109	0.0111	CbGeAlD
L-Carnitine—SLC22A4—tendon—systemic scleroderma	0.00103	0.0106	CbGeAlD
L-Carnitine—MPO—lung—systemic scleroderma	0.000995	0.0102	CbGeAlD
L-Carnitine—SLC22A4—lung—systemic scleroderma	0.000908	0.00928	CbGeAlD
L-Carnitine—SLC22A5—skin of body—systemic scleroderma	0.0009	0.00919	CbGeAlD
L-Carnitine—SLC22A5—digestive system—systemic scleroderma	0.00072	0.00735	CbGeAlD
L-Carnitine—SLC22A5—tendon—systemic scleroderma	0.000685	0.007	CbGeAlD
L-Carnitine—SLC22A5—lung—systemic scleroderma	0.000601	0.00614	CbGeAlD
L-Carnitine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000418	0.00178	CcSEcCtD
L-Carnitine—Dysgeusia—Lisinopril—systemic scleroderma	0.000417	0.00177	CcSEcCtD
L-Carnitine—Cough—Mycophenolic acid—systemic scleroderma	0.000412	0.00176	CcSEcCtD
L-Carnitine—Back pain—Lisinopril—systemic scleroderma	0.000412	0.00175	CcSEcCtD
L-Carnitine—Vomiting—Pentoxifylline—systemic scleroderma	0.000412	0.00175	CcSEcCtD
L-Carnitine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000409	0.00174	CcSEcCtD
L-Carnitine—Muscle spasms—Lisinopril—systemic scleroderma	0.000409	0.00174	CcSEcCtD
L-Carnitine—Rash—Pentoxifylline—systemic scleroderma	0.000408	0.00174	CcSEcCtD
L-Carnitine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000408	0.00174	CcSEcCtD
L-Carnitine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000408	0.00174	CcSEcCtD
L-Carnitine—Headache—Pentoxifylline—systemic scleroderma	0.000406	0.00173	CcSEcCtD
L-Carnitine—Myalgia—Mycophenolic acid—systemic scleroderma	0.000402	0.00171	CcSEcCtD
L-Carnitine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000402	0.00171	CcSEcCtD
L-Carnitine—Infection—Leflunomide—systemic scleroderma	0.000402	0.00171	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000401	0.00171	CcSEcCtD
L-Carnitine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000401	0.00171	CcSEcCtD
L-Carnitine—Asthenia—Mometasone—systemic scleroderma	0.000401	0.00171	CcSEcCtD
L-Carnitine—Eye disorder—Mycophenolate mofetil—systemic scleroderma	0.0004	0.0017	CcSEcCtD
L-Carnitine—Hypotension—Azathioprine—systemic scleroderma	0.0004	0.0017	CcSEcCtD
L-Carnitine—Pruritus—Mometasone—systemic scleroderma	0.000395	0.00168	CcSEcCtD
L-Carnitine—Tachycardia—Leflunomide—systemic scleroderma	0.000395	0.00168	CcSEcCtD
L-Carnitine—Anaemia—Lisinopril—systemic scleroderma	0.000393	0.00167	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.00039	0.00166	CcSEcCtD
L-Carnitine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000389	0.00165	CcSEcCtD
L-Carnitine—Abdominal pain—Captopril—systemic scleroderma	0.000388	0.00165	CcSEcCtD
L-Carnitine—Body temperature increased—Captopril—systemic scleroderma	0.000388	0.00165	CcSEcCtD
L-Carnitine—Anorexia—Leflunomide—systemic scleroderma	0.000385	0.00164	CcSEcCtD
L-Carnitine—Nausea—Pentoxifylline—systemic scleroderma	0.000385	0.00164	CcSEcCtD
L-Carnitine—Infection—Mycophenolic acid—systemic scleroderma	0.000383	0.00163	CcSEcCtD
L-Carnitine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000383	0.00163	CcSEcCtD
L-Carnitine—Vertigo—Lisinopril—systemic scleroderma	0.000382	0.00163	CcSEcCtD
L-Carnitine—Diarrhoea—Mometasone—systemic scleroderma	0.000382	0.00163	CcSEcCtD
L-Carnitine—Hypotension—Leflunomide—systemic scleroderma	0.000378	0.00161	CcSEcCtD
L-Carnitine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000376	0.0016	CcSEcCtD
L-Carnitine—Palpitations—Lisinopril—systemic scleroderma	0.000376	0.0016	CcSEcCtD
L-Carnitine—Cough—Lisinopril—systemic scleroderma	0.000371	0.00158	CcSEcCtD
L-Carnitine—Muscular weakness—Prednisone—systemic scleroderma	0.00037	0.00158	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00037	0.00157	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000368	0.00157	CcSEcCtD
L-Carnitine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000368	0.00157	CcSEcCtD
L-Carnitine—Insomnia—Leflunomide—systemic scleroderma	0.000366	0.00156	CcSEcCtD
L-Carnitine—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000365	0.00155	CcSEcCtD
L-Carnitine—Paraesthesia—Leflunomide—systemic scleroderma	0.000363	0.00155	CcSEcCtD
L-Carnitine—Myalgia—Lisinopril—systemic scleroderma	0.000362	0.00154	CcSEcCtD
L-Carnitine—Chest pain—Lisinopril—systemic scleroderma	0.000362	0.00154	CcSEcCtD
L-Carnitine—Anxiety—Lisinopril—systemic scleroderma	0.000361	0.00154	CcSEcCtD
L-Carnitine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00154	CcSEcCtD
L-Carnitine—Dyspnoea—Leflunomide—systemic scleroderma	0.00036	0.00153	CcSEcCtD
L-Carnitine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00036	0.00153	CcSEcCtD
L-Carnitine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000359	0.00153	CcSEcCtD
L-Carnitine—Dyspepsia—Leflunomide—systemic scleroderma	0.000356	0.00151	CcSEcCtD
L-Carnitine—Vomiting—Mometasone—systemic scleroderma	0.000355	0.00151	CcSEcCtD
L-Carnitine—Rash—Mometasone—systemic scleroderma	0.000352	0.0015	CcSEcCtD
L-Carnitine—Asthenia—Captopril—systemic scleroderma	0.000352	0.0015	CcSEcCtD
L-Carnitine—Dermatitis—Mometasone—systemic scleroderma	0.000352	0.0015	CcSEcCtD
L-Carnitine—Decreased appetite—Leflunomide—systemic scleroderma	0.000351	0.0015	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000351	0.0015	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00035	0.00149	CcSEcCtD
L-Carnitine—Headache—Mometasone—systemic scleroderma	0.00035	0.00149	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000349	0.00149	CcSEcCtD
L-Carnitine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000349	0.00148	CcSEcCtD
L-Carnitine—Pruritus—Captopril—systemic scleroderma	0.000347	0.00148	CcSEcCtD
L-Carnitine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000346	0.00147	CcSEcCtD
L-Carnitine—Pain—Leflunomide—systemic scleroderma	0.000346	0.00147	CcSEcCtD
L-Carnitine—Constipation—Leflunomide—systemic scleroderma	0.000346	0.00147	CcSEcCtD
L-Carnitine—Infection—Lisinopril—systemic scleroderma	0.000345	0.00147	CcSEcCtD
L-Carnitine—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000345	0.00147	CcSEcCtD
L-Carnitine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000344	0.00146	CcSEcCtD
L-Carnitine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00034	0.00145	CcSEcCtD
L-Carnitine—Tachycardia—Lisinopril—systemic scleroderma	0.000339	0.00144	CcSEcCtD
L-Carnitine—Abdominal pain—Azathioprine—systemic scleroderma	0.000338	0.00144	CcSEcCtD
L-Carnitine—Body temperature increased—Azathioprine—systemic scleroderma	0.000338	0.00144	CcSEcCtD
L-Carnitine—Diarrhoea—Captopril—systemic scleroderma	0.000336	0.00143	CcSEcCtD
L-Carnitine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000335	0.00143	CcSEcCtD
L-Carnitine—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000335	0.00143	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000333	0.00142	CcSEcCtD
L-Carnitine—Nausea—Mometasone—systemic scleroderma	0.000332	0.00141	CcSEcCtD
L-Carnitine—Anorexia—Lisinopril—systemic scleroderma	0.000331	0.00141	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000331	0.00141	CcSEcCtD
L-Carnitine—Weight increased—Prednisone—systemic scleroderma	0.00033	0.00141	CcSEcCtD
L-Carnitine—Pain—Mycophenolic acid—systemic scleroderma	0.00033	0.0014	CcSEcCtD
L-Carnitine—Constipation—Mycophenolic acid—systemic scleroderma	0.00033	0.0014	CcSEcCtD
L-Carnitine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00033	0.0014	CcSEcCtD
L-Carnitine—Weight decreased—Prednisone—systemic scleroderma	0.000328	0.0014	CcSEcCtD
L-Carnitine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00139	CcSEcCtD
L-Carnitine—Hypotension—Lisinopril—systemic scleroderma	0.000325	0.00138	CcSEcCtD
L-Carnitine—Dizziness—Captopril—systemic scleroderma	0.000324	0.00138	CcSEcCtD
L-Carnitine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000323	0.00138	CcSEcCtD
L-Carnitine—Depression—Prednisone—systemic scleroderma	0.000323	0.00137	CcSEcCtD
L-Carnitine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000322	0.00137	CcSEcCtD
L-Carnitine—Abdominal pain—Leflunomide—systemic scleroderma	0.00032	0.00136	CcSEcCtD
L-Carnitine—Body temperature increased—Leflunomide—systemic scleroderma	0.00032	0.00136	CcSEcCtD
L-Carnitine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00135	CcSEcCtD
L-Carnitine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00135	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000317	0.00135	CcSEcCtD
L-Carnitine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000316	0.00135	CcSEcCtD
L-Carnitine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000315	0.00134	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000315	0.00134	CcSEcCtD
L-Carnitine—Insomnia—Lisinopril—systemic scleroderma	0.000314	0.00134	CcSEcCtD
L-Carnitine—Paraesthesia—Lisinopril—systemic scleroderma	0.000312	0.00133	CcSEcCtD
L-Carnitine—Vomiting—Captopril—systemic scleroderma	0.000312	0.00133	CcSEcCtD
L-Carnitine—Dyspnoea—Lisinopril—systemic scleroderma	0.00031	0.00132	CcSEcCtD
L-Carnitine—Rash—Captopril—systemic scleroderma	0.000309	0.00132	CcSEcCtD
L-Carnitine—Dermatitis—Captopril—systemic scleroderma	0.000309	0.00132	CcSEcCtD
L-Carnitine—Headache—Captopril—systemic scleroderma	0.000307	0.00131	CcSEcCtD
L-Carnitine—Dyspepsia—Lisinopril—systemic scleroderma	0.000306	0.0013	CcSEcCtD
L-Carnitine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000305	0.0013	CcSEcCtD
L-Carnitine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000305	0.0013	CcSEcCtD
L-Carnitine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000302	0.00129	CcSEcCtD
L-Carnitine—Decreased appetite—Lisinopril—systemic scleroderma	0.000302	0.00129	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.0003	0.00128	CcSEcCtD
L-Carnitine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000298	0.00127	CcSEcCtD
L-Carnitine—Pain—Lisinopril—systemic scleroderma	0.000297	0.00126	CcSEcCtD
L-Carnitine—Constipation—Lisinopril—systemic scleroderma	0.000297	0.00126	CcSEcCtD
L-Carnitine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000297	0.00126	CcSEcCtD
L-Carnitine—Diarrhoea—Azathioprine—systemic scleroderma	0.000293	0.00125	CcSEcCtD
L-Carnitine—Haemoglobin—Prednisone—systemic scleroderma	0.000292	0.00124	CcSEcCtD
L-Carnitine—Nausea—Captopril—systemic scleroderma	0.000291	0.00124	CcSEcCtD
L-Carnitine—Haemorrhage—Prednisone—systemic scleroderma	0.00029	0.00124	CcSEcCtD
L-Carnitine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00029	0.00124	CcSEcCtD
L-Carnitine—Asthenia—Leflunomide—systemic scleroderma	0.00029	0.00123	CcSEcCtD
L-Carnitine—Pruritus—Leflunomide—systemic scleroderma	0.000286	0.00122	CcSEcCtD
L-Carnitine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000284	0.00121	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000284	0.00121	CcSEcCtD
L-Carnitine—Dizziness—Azathioprine—systemic scleroderma	0.000283	0.00121	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00118	CcSEcCtD
L-Carnitine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000277	0.00118	CcSEcCtD
L-Carnitine—Diarrhoea—Leflunomide—systemic scleroderma	0.000277	0.00118	CcSEcCtD
L-Carnitine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000275	0.00117	CcSEcCtD
L-Carnitine—Abdominal pain—Lisinopril—systemic scleroderma	0.000275	0.00117	CcSEcCtD
L-Carnitine—Body temperature increased—Lisinopril—systemic scleroderma	0.000275	0.00117	CcSEcCtD
L-Carnitine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000273	0.00116	CcSEcCtD
L-Carnitine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000273	0.00116	CcSEcCtD
L-Carnitine—Vomiting—Azathioprine—systemic scleroderma	0.000272	0.00116	CcSEcCtD
L-Carnitine—Eye disorder—Prednisone—systemic scleroderma	0.000271	0.00116	CcSEcCtD
L-Carnitine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000271	0.00116	CcSEcCtD
L-Carnitine—Rash—Azathioprine—systemic scleroderma	0.00027	0.00115	CcSEcCtD
L-Carnitine—Dermatitis—Azathioprine—systemic scleroderma	0.00027	0.00115	CcSEcCtD
L-Carnitine—Depression—Methotrexate—systemic scleroderma	0.00027	0.00115	CcSEcCtD
L-Carnitine—Headache—Azathioprine—systemic scleroderma	0.000268	0.00114	CcSEcCtD
L-Carnitine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000268	0.00114	CcSEcCtD
L-Carnitine—Dizziness—Leflunomide—systemic scleroderma	0.000267	0.00114	CcSEcCtD
L-Carnitine—Renal failure—Methotrexate—systemic scleroderma	0.000266	0.00113	CcSEcCtD
L-Carnitine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000265	0.00113	CcSEcCtD
L-Carnitine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000264	0.00112	CcSEcCtD
L-Carnitine—Angiopathy—Prednisone—systemic scleroderma	0.000264	0.00112	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000263	0.00112	CcSEcCtD
L-Carnitine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00111	CcSEcCtD
L-Carnitine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00026	0.00111	CcSEcCtD
L-Carnitine—Arrhythmia—Prednisone—systemic scleroderma	0.000259	0.0011	CcSEcCtD
L-Carnitine—Vomiting—Leflunomide—systemic scleroderma	0.000257	0.00109	CcSEcCtD
L-Carnitine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000256	0.00109	CcSEcCtD
L-Carnitine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000255	0.00109	CcSEcCtD
L-Carnitine—Rash—Leflunomide—systemic scleroderma	0.000255	0.00109	CcSEcCtD
L-Carnitine—Dermatitis—Leflunomide—systemic scleroderma	0.000255	0.00108	CcSEcCtD
L-Carnitine—Nausea—Azathioprine—systemic scleroderma	0.000254	0.00108	CcSEcCtD
L-Carnitine—Headache—Leflunomide—systemic scleroderma	0.000253	0.00108	CcSEcCtD
L-Carnitine—Asthenia—Lisinopril—systemic scleroderma	0.000249	0.00106	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000249	0.00106	CcSEcCtD
L-Carnitine—Pruritus—Lisinopril—systemic scleroderma	0.000246	0.00105	CcSEcCtD
L-Carnitine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000245	0.00104	CcSEcCtD
L-Carnitine—Haemoglobin—Methotrexate—systemic scleroderma	0.000244	0.00104	CcSEcCtD
L-Carnitine—Rash—Mycophenolic acid—systemic scleroderma	0.000243	0.00104	CcSEcCtD
L-Carnitine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000243	0.00103	CcSEcCtD
L-Carnitine—Haemorrhage—Methotrexate—systemic scleroderma	0.000243	0.00103	CcSEcCtD
L-Carnitine—Headache—Mycophenolic acid—systemic scleroderma	0.000242	0.00103	CcSEcCtD
L-Carnitine—Pharyngitis—Methotrexate—systemic scleroderma	0.000241	0.00103	CcSEcCtD
L-Carnitine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00102	CcSEcCtD
L-Carnitine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00102	CcSEcCtD
L-Carnitine—Nausea—Leflunomide—systemic scleroderma	0.00024	0.00102	CcSEcCtD
L-Carnitine—Diarrhoea—Lisinopril—systemic scleroderma	0.000238	0.00101	CcSEcCtD
L-Carnitine—Anaemia—Prednisone—systemic scleroderma	0.000234	0.000995	CcSEcCtD
L-Carnitine—Dizziness—Lisinopril—systemic scleroderma	0.00023	0.000978	CcSEcCtD
L-Carnitine—Nausea—Mycophenolic acid—systemic scleroderma	0.000229	0.000975	CcSEcCtD
L-Carnitine—Vertigo—Prednisone—systemic scleroderma	0.000227	0.000967	CcSEcCtD
L-Carnitine—Eye disorder—Methotrexate—systemic scleroderma	0.000227	0.000966	CcSEcCtD
L-Carnitine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000955	CcSEcCtD
L-Carnitine—Vomiting—Lisinopril—systemic scleroderma	0.000221	0.00094	CcSEcCtD
L-Carnitine—Angiopathy—Methotrexate—systemic scleroderma	0.00022	0.000937	CcSEcCtD
L-Carnitine—Rash—Lisinopril—systemic scleroderma	0.000219	0.000932	CcSEcCtD
L-Carnitine—Convulsion—Prednisone—systemic scleroderma	0.000219	0.000932	CcSEcCtD
L-Carnitine—Dermatitis—Lisinopril—systemic scleroderma	0.000219	0.000932	CcSEcCtD
L-Carnitine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00093	CcSEcCtD
L-Carnitine—Hypertension—Prednisone—systemic scleroderma	0.000218	0.000929	CcSEcCtD
L-Carnitine—Headache—Lisinopril—systemic scleroderma	0.000218	0.000926	CcSEcCtD
L-Carnitine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000917	CcSEcCtD
L-Carnitine—Myalgia—Prednisone—systemic scleroderma	0.000215	0.000916	CcSEcCtD
L-Carnitine—Anxiety—Prednisone—systemic scleroderma	0.000215	0.000913	CcSEcCtD
L-Carnitine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000208	0.000887	CcSEcCtD
L-Carnitine—Dysgeusia—Methotrexate—systemic scleroderma	0.000207	0.000881	CcSEcCtD
L-Carnitine—Nausea—Lisinopril—systemic scleroderma	0.000206	0.000878	CcSEcCtD
L-Carnitine—Infection—Prednisone—systemic scleroderma	0.000205	0.000873	CcSEcCtD
L-Carnitine—Back pain—Methotrexate—systemic scleroderma	0.000204	0.00087	CcSEcCtD
L-Carnitine—Tachycardia—Prednisone—systemic scleroderma	0.000201	0.000857	CcSEcCtD
L-Carnitine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000857	CcSEcCtD
L-Carnitine—Anorexia—Prednisone—systemic scleroderma	0.000197	0.000837	CcSEcCtD
L-Carnitine—Anaemia—Methotrexate—systemic scleroderma	0.000195	0.000831	CcSEcCtD
L-Carnitine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000824	CcSEcCtD
L-Carnitine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000817	CcSEcCtD
L-Carnitine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000816	CcSEcCtD
L-Carnitine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000191	0.000812	CcSEcCtD
L-Carnitine—Vertigo—Methotrexate—systemic scleroderma	0.00019	0.000808	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000188	0.0008	CcSEcCtD
L-Carnitine—Insomnia—Prednisone—systemic scleroderma	0.000187	0.000794	CcSEcCtD
L-Carnitine—Paraesthesia—Prednisone—systemic scleroderma	0.000185	0.000789	CcSEcCtD
L-Carnitine—Cough—Methotrexate—systemic scleroderma	0.000184	0.000785	CcSEcCtD
L-Carnitine—Convulsion—Methotrexate—systemic scleroderma	0.000183	0.000779	CcSEcCtD
L-Carnitine—Dyspepsia—Prednisone—systemic scleroderma	0.000182	0.000773	CcSEcCtD
L-Carnitine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000181	0.00077	CcSEcCtD
L-Carnitine—Chest pain—Methotrexate—systemic scleroderma	0.00018	0.000766	CcSEcCtD
L-Carnitine—Myalgia—Methotrexate—systemic scleroderma	0.00018	0.000766	CcSEcCtD
L-Carnitine—Decreased appetite—Prednisone—systemic scleroderma	0.000179	0.000763	CcSEcCtD
L-Carnitine—Constipation—Prednisone—systemic scleroderma	0.000176	0.000751	CcSEcCtD
L-Carnitine—Infection—Methotrexate—systemic scleroderma	0.000171	0.000729	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000169	0.000718	CcSEcCtD
L-Carnitine—Anorexia—Methotrexate—systemic scleroderma	0.000164	0.0007	CcSEcCtD
L-Carnitine—Abdominal pain—Prednisone—systemic scleroderma	0.000163	0.000694	CcSEcCtD
L-Carnitine—Body temperature increased—Prednisone—systemic scleroderma	0.000163	0.000694	CcSEcCtD
L-Carnitine—Hypotension—Methotrexate—systemic scleroderma	0.000161	0.000686	CcSEcCtD
L-Carnitine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000157	0.000669	CcSEcCtD
L-Carnitine—Insomnia—Methotrexate—systemic scleroderma	0.000156	0.000664	CcSEcCtD
L-Carnitine—Paraesthesia—Methotrexate—systemic scleroderma	0.000155	0.000659	CcSEcCtD
L-Carnitine—Dyspnoea—Methotrexate—systemic scleroderma	0.000154	0.000654	CcSEcCtD
L-Carnitine—Hypersensitivity—Prednisone—systemic scleroderma	0.000152	0.000647	CcSEcCtD
L-Carnitine—Dyspepsia—Methotrexate—systemic scleroderma	0.000152	0.000646	CcSEcCtD
L-Carnitine—Decreased appetite—Methotrexate—systemic scleroderma	0.00015	0.000638	CcSEcCtD
L-Carnitine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000149	0.000634	CcSEcCtD
L-Carnitine—Asthenia—Prednisone—systemic scleroderma	0.000148	0.00063	CcSEcCtD
L-Carnitine—Pain—Methotrexate—systemic scleroderma	0.000147	0.000628	CcSEcCtD
L-Carnitine—Pruritus—Prednisone—systemic scleroderma	0.000146	0.000621	CcSEcCtD
L-Carnitine—Diarrhoea—Prednisone—systemic scleroderma	0.000141	0.000601	CcSEcCtD
L-Carnitine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000141	0.0006	CcSEcCtD
L-Carnitine—Dizziness—Prednisone—systemic scleroderma	0.000136	0.000581	CcSEcCtD
L-Carnitine—Abdominal pain—Methotrexate—systemic scleroderma	0.000136	0.00058	CcSEcCtD
L-Carnitine—Body temperature increased—Methotrexate—systemic scleroderma	0.000136	0.00058	CcSEcCtD
L-Carnitine—Vomiting—Prednisone—systemic scleroderma	0.000131	0.000558	CcSEcCtD
L-Carnitine—Rash—Prednisone—systemic scleroderma	0.00013	0.000554	CcSEcCtD
L-Carnitine—Dermatitis—Prednisone—systemic scleroderma	0.00013	0.000553	CcSEcCtD
L-Carnitine—Headache—Prednisone—systemic scleroderma	0.000129	0.00055	CcSEcCtD
L-Carnitine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000127	0.000541	CcSEcCtD
L-Carnitine—Asthenia—Methotrexate—systemic scleroderma	0.000124	0.000527	CcSEcCtD
L-Carnitine—Nausea—Prednisone—systemic scleroderma	0.000123	0.000522	CcSEcCtD
L-Carnitine—Pruritus—Methotrexate—systemic scleroderma	0.000122	0.000519	CcSEcCtD
L-Carnitine—Diarrhoea—Methotrexate—systemic scleroderma	0.000118	0.000502	CcSEcCtD
L-Carnitine—Dizziness—Methotrexate—systemic scleroderma	0.000114	0.000485	CcSEcCtD
L-Carnitine—Vomiting—Methotrexate—systemic scleroderma	0.00011	0.000467	CcSEcCtD
L-Carnitine—Rash—Methotrexate—systemic scleroderma	0.000109	0.000463	CcSEcCtD
L-Carnitine—Dermatitis—Methotrexate—systemic scleroderma	0.000109	0.000462	CcSEcCtD
L-Carnitine—Headache—Methotrexate—systemic scleroderma	0.000108	0.00046	CcSEcCtD
L-Carnitine—Nausea—Methotrexate—systemic scleroderma	0.000102	0.000436	CcSEcCtD
